Characterization and stability testing of itraconazole solid dispersions containing crystallization inhibitors

American Journal of Drug Discovery and Development

Volumn 1, Issue 3, 2011, Pages 144-149

  Badawi, Alia A ^a   El Nabarawi, Mohamed Ahmed ^a   El Setouhy, Doaa Ahmed ^a   Alsammit, Sami A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Itraconazole; Solid dispersion; Stability study; Ternary solid dispersion

Indexed keywords

EUDRAGIT; ITRACONAZOLE; POLOXAMER; POLYMER; POVIDONE;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; SOLID DISPERSION; TEMPERATURE SENSITIVITY; THERMOGRAPHY; X RAY DIFFRACTION;

EID: 79959584970     PISSN: 2150427X     EISSN: 21504296     Source Type: Journal    
DOI: 10.3923/ajdd.2011.144.159     Document Type: Article

References (33)

1. Chen, Y., G.G.Z. Zhang, J. Neilly, K. Marsh, D. Mawhmney and Y.D. Sanzgiri, 2004. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int. J. Pharm., 286: 69-80.
2. Craig, D.Q.M., 1990. Polyethylene glycols and drug release. Drug Dev. Ind. Pharm., 16: 2501-2526.
3. Damian, F., N. Blaton, R. Kinget and G. Van den Mooter, 2002. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int. J. Pharm, 244: 87-98.
4. Dordunoo, S.K, J.L. Ford and M.H. Rubinstein, 1997. Physical stability of solid dispersions containing triamterene or temazepam in polyethylene glycols. J. Pharm. Pharmacol, 149: 390-396.
5. Fitzpatrick, S, J.F. McCabe, C.R. Petts and S.W. Booth, 2002. Effect of moisture on polyvinylpyrrolidone in accelerated stability testing. Int. J. Pharm, 246: 143-151.
6. Gharaei-Fathabad, E, 2011. Biosurfactants in pharmaceutical industry: A mini-review. Am. J. Drug Discovery Dev., 1: 58-69.
7. Hamaguchi, T, D. Shinkuma, Y. Yamanaka, M. Miyake, S. Tamura and N. Mizuno, 1995. Factors affecting dissolution rate of sulpiride from tablets coated with polyvinylacetal diethyl amino acetate, a gastric fluid-soluble polymer I. Effect of ionic strength of gastrointestinal fluids. Chem. Pharm. Bull, 43: 1204-1211.
8. Hisham Abou-Auda, S, A.S. Bawazir, AY. Asm, A.O. Gubara and M.B. AI-Hadiya, 2006. Studies on solubility, bioavailability and hypoglycemic activity of gliclazide P-cyclodextrin complexes. Int. J. Pharmacol, 2: 656-663.
9. Jain, S. and V.N. Sehgal, 2001. Itraconazole: An effective oral antifungal for onchomychosis. Int. J. Dermatol, 40: 1-5.
10. Khan, G.M, F. Wazir and J.b. Zhu, 2001. Ibuprofen-cyclodextrin inclusion complexes: Evaluation of different complexation methods. J. Medical Sci, 1: 193-199.
11. Konno, H. and L. Taylor, 2008. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm. Res, 25: 969-978.
12. Kotiyan, P.N. and P.R. Vavia, 2001. Eudragits: Role as crystallization inhibitors in drug-inadhesive transdermal systems of estradiol. Eur. J. Pharm. Biopharm, 52: 173-180.
13. Lobenberg, R. and G.L. Amidon, 2000. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm, 50: 3-12.
14. Lokhande, P.D, K.R. Gawai, KM. Kodam, BY. Waghmare, A.R. Chabukswar and S.C. Jagdale, 2006. Water soluble amide derivatives of polyene antibiotic and their antifungal activity. Trends Applied Sci. Res, 1: 529-533.
15. Nesseem, D.I, 2001. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J. Pharm. Biomed. Anal, 26: 387-399.
16. Odds, F.C, M. Oris, P. Van Dorsselaer and F. Van Gerven, 2000. Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida and Cryptococcus infections. Antimicrob. Agents Chemother, 44: 3180-3183.
17. Okochi, H. and M. Nakano, 2000. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv. Drug Delivery Rev., 45: 5-26.
18. Okonogi, S. and S. Puttipipatkhachorn, 2006. Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech, 7: E52-E52.
19. Peeters, J., P. Neeskens, J.P. Tollenaere, P. van Remoortere and ME. Brewster, 2002. Characterization of the interaction of 2-hydroxypropyl-andbeta,-cyclodextrin with itraconazole at pH 2, 4 and 7. J. Pharm. Sci, 91: 1414-1422.
20. Ryan, J.A., 1986. Compressed pellet X-ray diffraction monitoring for optimization of crystallinity in lyophilized solids: Imipenem: Cilastatin sodium case. J. Pharm. Sci., 75: 805-807.
21. Salem, I.I. and N. Duzgunes, 2003. Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. Int. J. Pharm, 16: 403-414.
22. Seedher, N. and P. Sharma, 2007. Solubility and stability enhancement of poorly-soluble drugs clarithromycin and prednisolone by combination with other drugs. Int. J. Biol. Chem, 1: 229-236.
23. Shim, S.Y, C.W. Ji, H. Sah, E.S. Park and B.J. Lee, 2006. Characterization of itraconazole semisolid dosage forms prepared by hot melt technique. Arch. Pharm. Res, 29: 1055-1060.
24. Sinswat, P, X. Gao, M.J. Yacaman, R.O. Williams III and K.P. Johnston, 2005. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution. Int. J. Pharm, 302: 113-124.
25. Six, K, H. Berghmans, C. Leuner, J. Dressman and K. Van Werde et al., 2003. Characterization of solid dispersions of itraconazole and hydroxypropyl methylcellulose prepared by melt extrusion, part II. Pharm. Res, 20: 1047-1054.
26. Trapani, G, A. Latrofa, M. Franco, A. Lopedota, E. Maciocco and G. Liso, 1998. Water-soluble salts of aminoacid esters of the anesthetic agent propofol. Int. J. Pharm, 175: 195-204.
27. Vasconcelos, T, B. Sarmento and P. Costa, 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today, 12: 1068-1075.
28. Verreck, G., K. Six, G. Van den Mooter, L. Baert, J. Peeters and M.E. Brewster, 2003. Characterization of solid dispersions of itraconazole and hydroxypropyl methylcellulose prepared by melt extrusion, part I. Int. J. Pharm, 251: 165-174.
29. Verreck, G, A. Decorte, K. Heymans, J. Adriaensen and D. Cleeren et al., 2005. The effect of pressurized carbon dioxide as a temporary plasticizer and foaming agent on the hot stage extrusion process and extrudate properties of solid dispersions of itraconazole with PVP-VA 64. Eur. J. Pharm. Sci, 26: 349-358.
30. Vippagunta, S.R, K.A. Maul, S. Tallavajhala and D.J.W. Grant, 2002. Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm, 236: 111-123.
31. Wang, X, A. Michoel and G. Van den Mooter, 2005. Solid state characterization of ternary solid dispersions composed of PVPVA64, Myrj 64 and itraconazole. Int. J. Pharm, 303: 54-61.
32. Willems, L, R. Van Der Geest and K. De Beule, 2001. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J. Clin. Pharm. Ther, 26: 159-169.
33. Yu, L.X, G.L. Amidon, JE. Polli, H. Zhao and M.U. Mehta et al, 2002. Biopharmaceutics classification system: The scientific basis forbiowaiver extensions. Pharm. Res, 19: 921-925.